RU93032579A - METHOD OF TREATING AUTOIMMUNE DISEASES AND LEUKEMIA WITH AUTOIMMUNE MANIFESTATIONS - Google Patents
METHOD OF TREATING AUTOIMMUNE DISEASES AND LEUKEMIA WITH AUTOIMMUNE MANIFESTATIONSInfo
- Publication number
- RU93032579A RU93032579A RU93032579/14A RU93032579A RU93032579A RU 93032579 A RU93032579 A RU 93032579A RU 93032579/14 A RU93032579/14 A RU 93032579/14A RU 93032579 A RU93032579 A RU 93032579A RU 93032579 A RU93032579 A RU 93032579A
- Authority
- RU
- Russia
- Prior art keywords
- autoimmune
- manifestations
- leukemia
- treating
- autoimmune diseases
- Prior art date
Links
- 230000001363 autoimmune Effects 0.000 title claims 3
- 206010003816 Autoimmune disease Diseases 0.000 title claims 2
- 206010024324 Leukaemias Diseases 0.000 title claims 2
- 102000003852 Autoantibodies Human genes 0.000 claims 1
- 108090000206 Autoantibodies Proteins 0.000 claims 1
- 210000004698 Lymphocytes Anatomy 0.000 claims 1
- 102000004965 antibodies Human genes 0.000 claims 1
- 108090001123 antibodies Proteins 0.000 claims 1
- 239000000427 antigen Substances 0.000 claims 1
- 102000038129 antigens Human genes 0.000 claims 1
- 108091007172 antigens Proteins 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 230000001900 immune effect Effects 0.000 claims 1
- 230000003053 immunization Effects 0.000 claims 1
- 239000003547 immunosorbent Substances 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 238000003786 synthesis reaction Methods 0.000 claims 1
- 230000002194 synthesizing Effects 0.000 claims 1
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU93032579A RU2085215C1 (en) | 1993-06-22 | 1993-06-22 | Method of treatment of leukosis with autoimmune manifestation induced in experiment |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU93032579A RU2085215C1 (en) | 1993-06-22 | 1993-06-22 | Method of treatment of leukosis with autoimmune manifestation induced in experiment |
Publications (2)
Publication Number | Publication Date |
---|---|
RU93032579A true RU93032579A (en) | 1996-06-10 |
RU2085215C1 RU2085215C1 (en) | 1997-07-27 |
Family
ID=20143749
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU93032579A RU2085215C1 (en) | 1993-06-22 | 1993-06-22 | Method of treatment of leukosis with autoimmune manifestation induced in experiment |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2085215C1 (en) |
-
1993
- 1993-06-22 RU RU93032579A patent/RU2085215C1/en active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2207788A (en) | Tumor immunotherapy using anti-idiotypic antibodies | |
NO982062D0 (en) | Humanized antibodies to human gp39, compositions containing them, and therapeutic use thereof | |
NL300353I1 (en) | Drugs with monoclonal antibodies that are specific to the human epidermal growth factor receptor | |
MD1374G2 (en) | Monoclonal immunostimulatin antibodies, method of obtaining thereof, cell lines, method of disease treatment and pharmaceutical composition | |
AU7519794A (en) | Methods for b-cell population control | |
NZ508381A (en) | Antibodies, antagonists and agonists of the death domain containing receptor 5 (DR5) | |
AU589351B2 (en) | Tumor specific monoclonal antibodies | |
IL92037A0 (en) | Novel family of high affinity,modified antibodies for cancer treatment | |
EP0674661A4 (en) | Assay and treatment for demyelinating diseases such as multiple sclerosis. | |
ES8607024A1 (en) | Monoclonal antibodies reactive with shared idiotypes on human antibodies to native DNA from patients with systemic Lupus erythematosus. | |
EP0194851A3 (en) | Human tumor therapy | |
AU625171B2 (en) | Specific excretion-secretion antigens of toxoplasma gondii, their expression products, processes for obtaining them and their diagnostic and prophylactic uses | |
RU93032579A (en) | METHOD OF TREATING AUTOIMMUNE DISEASES AND LEUKEMIA WITH AUTOIMMUNE MANIFESTATIONS | |
EP0328578A4 (en) | Antigen recognized by mca 16-88. | |
EP0537168A4 (en) | Ctaa 28a32, the antigen recognized by mca 28a32 | |
CA2038030A1 (en) | Synthetic peptides which contain sequences from factor viia, and the use thereof | |
AU3283693A (en) | Specific antibodies against activated platelets, the preparation thereof and the use thereof in diagnosis and therapy | |
EP0242154A3 (en) | A novel tumor-associated antigen | |
EP0243058A3 (en) | A novel tumor associated antigen | |
IL73281A0 (en) | Purified antigen isolated from sera of leukemia and lymphoma patients,novel antibodies to said antigen,methods of preparing same and diagnostic and therapeutic methods employing said antibody | |
AU1508088A (en) | Monoclonal antibodies to specific antigenic regions of the human immunodeficiency virus and methods for use | |
CA2151945A1 (en) | Assay and treatment for demyelinating diseases such as multiple sclerosis |